Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access March 1, 2008

β-Endorphin in pressor response to hyperventilation in elderly patients with essential and secondary hypertension

  • Fiorella Fontana EMAIL logo , Pasquale Bernardi , Carmine Pizzi , Rosanna Toro and Santi Spampinato
From the journal Open Medicine

Abstract

It has been observed that a distinct blood pressure (BP) response to prolonged and forced hyperventilation in adult patients with essential hypertension is associated with significant changes in plasma catecholamine and β-endorphin levels. This paper investigated whether hemodynamic and neuro-endocrine responses to hyperventilation in elderly patients with essential hypertension (n = 39, mean age 81 ± 3 years) differ from those in elderly patients with secondary hypertension (isolated systolic hypertension, bilateral chronic nephropathy, nephroangiosclerosis, diabetic nephropathy and hyperparathyroidism) (n = 39, mean age 80 ± 1 years). Plasma β-endorphin levels were normal in patients with essential hypertension and increased in patients with secondary hypertension. Plasma norepinephrine levels were normal in both populations. Hyperventilation decreased BP and norepinephrine levels and increased β-endorphin levels in essential hypertensive patients, whereas it did not significantly change BP or neuro-hormonal levels in secondary hypertensive patients. Hierarchical cluster analysis based on BP response to hyperventilation disclosed a sub-group of essential hypertensive patients with the highest basal levels of norepinephrine and the lowest β-endorphin levels, in whom the BP decrease following hyperventilation was correlated with the decrease in norepinephrine and increase in β-endorphin levels. This suggests that b-endorphin may be involved in modulating sympatho-adrenergic activity in elderly patients with essential hypertension.

[1] Barnes R.F., Raskind M., Gumbrecht G., Halter J.B., The effect of age on the plasma catecholamine response to mental stress in man, J. Clin. Endocrinol. Metab., 1982, 54, 64–69 http://dx.doi.org/10.1210/jcem-54-1-6410.1210/jcem-54-1-64Search in Google Scholar

[2] Rowe J.W., Troen B.R., Sympathetic nervous system and aging in man, Endocr. Rev., 1980, 1, 167–178 10.1210/edrv-1-2-167Search in Google Scholar

[3] Esler M.D., Thompson J.M., Kaye D.M., Turner A.G., Jennings G.L., Cox H.S., et al., Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors, Circulation, 1995, 91, 351–358 10.1161/01.CIR.91.2.351Search in Google Scholar

[4] Rowlands D.B., Stallard T.J., Littler W.A., Comparison of ambulatory blood pressure and cardiovascular reflexes in elderly hypertensives, elderly normotensives and young hypertensives, J. Hypertens., 1983, 1, 71–73 Search in Google Scholar

[5] Cugini P., Lucia P., Di Palma L., Re M., Canova R., Gasparrone L., et al., The circadian rhythm of atrial natriuretic peptide, vasoactive intestinal peptide, beta-endorphin and cortisol in healthy young and elderly subjects, Clin. Auton. Res., 1992, 2, 113–118 http://dx.doi.org/10.1007/BF0181966610.1007/BF01819666Search in Google Scholar

[6] Fontana F., Bernardi P., Spampinato S., Di Toro R., Bugiardini R., β-endorphin modulation of pressor response to hyperventilation in hypertensive patients, Peptides, 2002, 23, 911–918 http://dx.doi.org/10.1016/S0196-9781(02)00018-910.1016/S0196-9781(02)00018-9Search in Google Scholar

[7] Zheng X, Zhang T., Ding H., Wang C., Plasma levels of β-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine, Int. J. Cardiol., 1995, 51, 233–244 http://dx.doi.org/10.1016/0167-5273(95)02423-T10.1016/0167-5273(95)02423-TSearch in Google Scholar

[8] Aronin N., Krieger D.T., Plasma immunoreactive β-endorphin is elevated in uraemia, Clin. Endocrinol., 1983, 18, 459–464 10.1111/j.1365-2265.1983.tb02875.xSearch in Google Scholar PubMed

[9] Smith R., Grossman A., Gaillard R., Clement-Jones V., Ratter S., Mallinson J., et al., Studies on circulating met-enkephalin and β-endorphin: Normal subjects and patients with renal and adrenal disease, Clin. Endocrinol., 1981, 15, 291–300 10.1111/j.1365-2265.1981.tb00668.xSearch in Google Scholar PubMed

[10] Chalmers J., Pilowsky P., Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure, J. Hypertens., 1991, 9, 675–694 http://dx.doi.org/10.1097/00004872-199108000-0000110.1097/00004872-199108000-00001Search in Google Scholar PubMed

[11] Gaddis R.R., Dixon W.R., Modulation of peripheral adrenergic neurotransmission by metionine enkephalin, J. Pharmachol. Exp. Ther., 1982, 221, 282–287 Search in Google Scholar

[12] Bernardi P., Fontana F., Merlo Pich E., Spampinato S., Canossa M., Plasma endogenous opioid levels in acute myocardial infarction patients, with and without pain, Eur. Heart. J., 1992, 13, 1074–1079 10.1093/oxfordjournals.eurheartj.a060316Search in Google Scholar PubMed

[13] Fontana F., Bernardi P., Spampinato S., Boschi S., De Iasio R., Grossi G., Pressor effects of endogenous opioid system during acute episodes of blood pressure increases in hypertensive patients, Hypertension, 1997, 29, 105–110 10.1161/01.HYP.29.1.105Search in Google Scholar

[14] McCubbin J.A., Surwit R.S., Williams R.B. Jr, Endogenous opiate peptides, stress reactivity, and risk for hypertension, Hypertension, 1985, 7, 808–811 10.1161/01.HYP.7.5.808Search in Google Scholar

[15] Fontana F., Bernardi P., Merlo Pich E., Tartuferi L., Boschi S., Spampinato S., Opioid peptide modulation of circulatory response to hyperventilation in humans, Peptides, 2000, 21, 1223–1230 http://dx.doi.org/10.1016/S0196-9781(00)00263-110.1016/S0196-9781(00)00263-1Search in Google Scholar

[16] Fontana F., Bernardi P., Lanfranchi G.,. Pisati M.S., Merlo Pich E., Blood pressure response to hyperventilation test reflects daytime pressor profile, Hypertension, 2003, 41, 244–248 http://dx.doi.org/10.1161/01.HYP.0000052315.51182.3D10.1161/01.HYP.0000052315.51182.3DSearch in Google Scholar

[17] Guidelines Subcommittee, 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension, J. Hypertens., 1999, 17, 151–183 10.1097/00004872-199917020-00001Search in Google Scholar

[18] Grossi G., Bargossi A.M., Lucarelli C., Paradisi R., Sprovieri C., Sprovieri G., Improvements in automated analysis of catecholamine and related metabolites in biological samples by column switching high-performance liquid chromatography, J. Chromatogr., 1991, 541, 273–284 http://dx.doi.org/10.1016/S0021-9673(01)95999-010.1016/S0021-9673(01)95999-0Search in Google Scholar

[19] Fontana F., Bernardi P., Merlo Pich E., Boschi S., De Iasio R, Spampinato S., et al., Opioid peptide modulation of circulatory and endocrine response to mental stress in humans, Peptides, 1997, 18, 169–175 http://dx.doi.org/10.1016/S0196-9781(96)00319-110.1016/S0196-9781(96)00319-1Search in Google Scholar

[20] Romesburg C., Cluster analysis for researchers, Lulu press, North Carolina, 2004 Search in Google Scholar

[21] Pfeifer M.A., Weinberg C.R., Cook D., Best J.D., Reenan A., Halter J.B., Differential changes of autonomic nervous system function with age in man, Am. J. Med., 1983, 75, 249–258 http://dx.doi.org/10.1016/0002-9343(83)91201-910.1016/0002-9343(83)91201-9Search in Google Scholar

[22] Matzen S., Secher N.H., Knigge U., Pawelczyk J., Perko G., Iversen H., et al., Effect of serotonin receptor blockade on endocrine and cardiovascular responses to head-up tilt in humans, Acta Physiol. Scand., 1993, 149, 163–176 http://dx.doi.org/10.1111/j.1748-1716.1993.tb09609.x10.1111/j.1748-1716.1993.tb09609.xSearch in Google Scholar PubMed

[23] Sander-Jensen K., Mehlsen J., Secher N.H., Bach F.W., Bie P., Giese J., et al., Progressive central hypovolaemia in man resulting in a vasovagal syncope? Haemodynamic and endocrine variables during venous tourniquets of the thighs, Clin. Physiol., 1987, 7, 231–242 10.1111/j.1475-097X.1987.tb00164.xSearch in Google Scholar

[24] Dubocovich M.L., Langer S.Z., Pharmacological differentiation of presynaptic inhibitory α-adrenoceptors and opiate receptors in the cat nictitating membrane, Br. J. Pharmacol., 1980, 70, 383–388 10.1111/j.1476-5381.1980.tb08714.xSearch in Google Scholar

[25] Kumakura R,. Guidotti A, Yang H.Y.T., Saiani L., Costa E., A role for the opiate peptides that presumably coexist with acetylcholine in splanchnic nerves, In: Costa E., Trabucchi M. (Eds.), Neural peptides and neuronal communication, Raven Press, New York, 1980 Search in Google Scholar

[26] Catlin D.H., Gorelick D.A., Gerner R.H., Clinical pharmacology of b-endorphin in depression and schizophrenia, In: Verebey K. (Ed.), Opioids in mental illness: theories, clinical observations, and treatment possibilities, Annals of the New York Academy of Sciences, New York, 1982 Search in Google Scholar

[27] Bhattacharyya A., Das P., Hypertension in ederly—an overview, J. Indian Med. Assoc., 1999, 97, 96–101 Search in Google Scholar

[28] Cerasola G., Cottone S., D’Ignoto G., Grasso L., Carone M.B., Sympathetic activity in borderline and established hypertension in the elderly, J. Hypertens., 1988, 6, 55–58 http://dx.doi.org/10.1097/00004872-198801000-0001310.1097/00004872-198801000-00013Search in Google Scholar

[29] Dluhy R.G., Uncommon forms of secondary hypertension in older patients, Am. J. Hypertens., 1998, 11, 52–56 http://dx.doi.org/10.1016/S0895-7061(98)00011-910.1016/S0895-7061(98)00011-9Search in Google Scholar

[30] Sagie A., Larson M.G., Levy D., The natural history of borderline isolated systolic hypertension, N. Engl. J. Med., 1993, 329, 1912–1917 http://dx.doi.org/10.1056/NEJM19931223329260210.1056/NEJM199312233292602Search in Google Scholar

[31] Julius S., Valentini M., Consequences of the increased autonomic nervous drive in hypertension, heart failure and diabetes, Blood Press., 1998, 3, 5–13 10.1080/080370598438410-1Search in Google Scholar

[32] Wanke T., Lahrmann H., Auinger M., Merkle M., Formanek D., Ogris E., et al., Endogenous opioid system during inspiratory loading in patients with type I diabetes, Am. Rev. Respir. Dis., 1993, 148, 1335–1340 10.1164/ajrccm/148.5.1335Search in Google Scholar

[33] Wanke T., Auinger M., Formanek D., Merkle M., Lahrmann H., Ogris E., et al., Defective endogenous opioid response to exercise in type I diabetic patients, Metabolism, 1996, 45, 137–142 http://dx.doi.org/10.1016/S0026-0495(96)90043-810.1016/S0026-0495(96)90043-8Search in Google Scholar

Published Online: 2008-3-1
Published in Print: 2008-3-1

© 2008 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 25.4.2024 from https://www.degruyter.com/document/doi/10.2478/s11536-007-0071-x/html
Scroll to top button